{"id":"NCT02049515","sponsor":"SecuraBio","briefTitle":"A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07","officialTitle":"A Study of IPI-145 and Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Previously Enrolled in Study IPI-145-07 Duvelisib (IPI-145)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12","primaryCompletion":"2020-06-12","completion":"2020-06-12","firstPosted":"2014-01-30","resultsPosted":"2023-02-21","lastUpdate":"2023-09-21"},"enrollment":99,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"interventions":[{"type":"DRUG","name":"IPI-145","otherNames":["Duvelisib","Copiktra","PI3K Inhibitor"]},{"type":"DRUG","name":"Ofatumumab","otherNames":["Arzerra"]}],"arms":[{"label":"IPI-145","type":"EXPERIMENTAL"},{"label":"Ofatumumab","type":"ACTIVE_COMPARATOR"}],"summary":"A Phase 3 (extension) clinical trial to examine the efficacy of IPI-145 (duvelisib) monotherapy or ofatumumab monotherapy in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who experienced disease progression after treatment with IPI-145 or ofatumumab in study IPI-145-07 (NCT02004522).","primaryOutcome":{"measure":"Overall Response Rate (ORR)","timeFrame":"Until progressive disease (PD), death, or other anticancer therapy is initiated (up to 4.5 years)","effectByArm":[{"arm":"IPI-145","deltaMin":76.7,"sd":null},{"arm":"Ofatumumab","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":7},"locations":{"siteCount":69,"countries":["United States","Australia","Austria","Belgium","France","Germany","Hungary","Italy","New Zealand","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":68,"n":90},"commonTop":["Diarrhoea","Neutropenia","Pyrexia","Rash","Cough"]}}